Acacia Pharma Agrees To Be Bought By Eagle Pharma In €94.7 Mln Cash, Stock Deal

Acacia Pharma Group Plc (ACPH.BR) announced Monday its agreement to be acquired by Eagle Pharmaceuticals, Inc. (EGRX) by way of a scheme of arrangement in around 94.7 million euros cash and stock deal.

The total consideration equates to 0.90 euro for each Scheme Share. Under the terms of the proposed scheme of arrangement, each Scheme Shareholder will receive 0.68 euro in cash and 0.0049 New Eagle Shares. The cash portion of the deal represents approximately 75 percent of the total price, and the shares represent the remaining 25 percent.

The Acacia Directors consider the proposed transaction to be the best available option for Acacia Shareholders and intend unanimously to recommend that shareholders vote in favour of the Scheme.

Eagle has received irrevocable undertakings representing approximately 48.78 percent of the issued share capital of Acacia.

The Scheme is expected to become effective between the middle of May 2022 and 30 June 2022, subject to the satisfaction of the terms.

The agreement follows a comprehensive review and assessment of all strategic alternatives, including consideration of options to raise additional capital.

Acacia noted that it met its formulary goals for both Barhemsys and Byfavo in fiscal 2021 and sees significant future commercial potential for the products.

However, the company's standalone financial condition has been negatively impacted by physical access limitations caused by the global COVID-19 pandemic, and a significant latency of demand due to postponement of surgical procedures.

Accordingly, Acacia expects it would require a minimum of around $115 million of additional cash to fund operations to break-even, based on projections assuming break-even by early fiscal 2025.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Delta Air Lines is set to resume flights on its routes between the U.S. and Japan from October 30, 2002 in anticipation of easing of COVID-19-related travel restrictions, which were put in place two years ago. The airline joins American Airlines and United Airlines, who have reportedly announced the resumption of flights to Japan. Tech major Apple Inc. has asked corporate employees to return to offices at least three days a week by September 5, Bloomberg reported. The latest deadline was issued following several delays to its previous deadlines amid a resurgence in COVID-19 cases. As per the report, the company will require employees to work from offices on Tuesdays, Thursdays and a regular third day to be determined by... Retail giant Walmart reported Tuesday a net profit for the second quarter that grew 20.4 percent from last year, reflecting lower operating expenses and partially inflation driven revenue growth. The results were also driven by the rebound in international markets. Quarterly revenues topped analysts' expectations. The retailer also raised its adjusted earnings guidance for the full-year 2023.
Follow RTT